1. Introduction {#sec1}
===============

The ventilatory dead space fraction (*V* ~d~/*V* ~t~) is defined as the portion of tidal volume that does not participate in gas exchange because it does not reach perfused lung units. Clinically, *V* ~d~/*V* ~t~ may be measured using volumetric capnography and the Enghoff modification of the Bohr equation, which states$$\begin{matrix}
{\frac{V_{d}}{V_{t}} = \frac{\left( {P_{a}{CO}_{2} - P_{e}{CO}_{2}} \right)}{\left( {P_{a}{CO}_{2}} \right)},} \\
\end{matrix}$$where P~a~CO~2~ is the partial pressure of carbon dioxide in the arterial blood and P~e~CO~2~ is the partial pressure of carbon dioxide in exhaled air \[[@B1]\]. *V* ~d~/*V* ~t~ may increase in a variety of pathological situations, especially conditions with obstruction of the pulmonary vasculature \[[@B2]\]. Measuring *V* ~d~/*V* ~t~ requires arterial blood gas (ABG) sampling to measure P~a~CO~2~ \[[@B3]\]. Transcutaneous capnography (P~tc~CO~2~) has emerged as a noninvasive method of estimating P~a~CO~2~ \[[@B4]\]. The objective of our study was to evaluate the relationship between P~tc~CO~2~and P~a~CO~2~ in calculating *V* ~d~/*V* ~t~. We hypothesized that P~tc~CO~2~can be used as a substitute for P~a~CO~2~ in the calculation of *V* ~d~/*V* ~t~.

2. Methods {#sec2}
==========

This was a prospective pilot comparison study conducted at a single 383-bed urban, community-teaching hospital. We recruited thirty consecutive adult patients admitted to the Surgical Intensive Care Unit (SICU) after cardiac surgery from May 1, 2014, until December 1, 2014. We excluded patients who were extubated within 4 hours of arrival to the SICU. The Bridgeport Hospital Institutional Review Board (IRB) approved this study.

Volumetric capnography was performed within 12 hours of patient arrival to the SICU. A CAPNOSTAT® CO~2~ sensor was attached between the subject\'s endotracheal tube and the Y-piece of the ventilator circuit to obtain breath-by-breath volumetric capnography using NICO~2~ volumetric capnography (Philips-Respironics®, Wallingford, CT). We measured P~tc~CO~2~using the Tosca 500 (Radiometer®, Copenhagen, Denmark), according to the manufacturer\'s instructions. A fully automated calibration of the transcutaneous CO~2~ sensor (Tosca sensor 92) containing a Stow-Severinghaus type electrode was performed using CAL-Gas (Radiometer), which contained 12% O~2~, 7% CO~2~, and 81% N~2~prior to each monitoring period and every time the membrane of the transcutaneous sensor was changed (every 14 days). First, the sensor probe and the subject\'s earlobe were cleaned with alcohol and dried prior to each measurement. Then, the sensor was placed on the earlobe after placing a drop of contact solution provided by the manufacturer and secured by means of an adhesive clip. No P~tc~CO~2~ values were collected until the ear lobe reached an appropriate temperature of 42°C and stable signals for both P~tc~CO~2~ and P~e~CO~2~ were achieved after at least 15 minutes. The P~tc~CO~2~ was recorded at the same time an arterial blood sample was collected from an existing radial arterial line, placed on ice, and sent immediately for standard blood gas analysis. P~a~CO~2~ was measured using the arterial blood gas sample analyzed with Cobas b221 blood gas analyzer (Roche®). Turnaround time for the result was under 10 minutes for all samples. We calculated *V* ~d~/*V* ~t~ using both simultaneously measured values for P~a~CO~2~ and P~tc~CO~2~ using NICO~2~ volumetric capnography according to the manufacturer\'s instructions. In this study, we used single measurements of P~e~CO~2~, P~a~CO~2~, and P~tc~CO~2~ to calculate *V* ~d~/*V* ~t~, with all values obtained simultaneously. The *V* ~d~/*V* ~t~ calculated using P~a~CO~2~ was considered the reference standard \[[@B5]\].

2.1. Statistical Analysis {#sec2.1}
-------------------------

Statistical analysis was performed using SPSS version 9.0. Results from descriptive statistics are presented as mean ± standard deviation (SD). Linear regression and Bland-Altman analyses were performed to compare the values of *V* ~d~/*V* ~t~ using P~tc~CO~2~and P~a~CO~2~ measurements.

3. Results {#sec3}
==========

30 consecutive postcardiac surgery patients were included and 30 separate volumetric capnography measurements were obtained. Statistical description of the study population can be found in [Table 1](#tab1){ref-type="table"}. 24 patients were males, mean age was 68.25 ± 6.36 years, and the mean Acute Physiology and Chronic Health Evaluation (APACHE) II score was 14.5 ± 3.92. The mean *V* ~d~/*V* ~t~ calculated using P~a~CO~2~ and P~tc~CO~2~ was 0.48 ± 0.09 and 0.53 ± 0.08, respectively, with a strong positive correlation between the two methods of calculation (Pearson\'s correlation = 0.87, *p* \< 0.05) as shown in [Figure 1](#fig1){ref-type="fig"}. Bland-Altman analysis showed a mean difference of −0.05 (95% CI: −0.01 to −0.09) between the two methods of *V* ~d~/*V* ~t~ measurements as shown in [Figure 2](#fig2){ref-type="fig"}.

4. Discussion {#sec4}
=============

Measuring *V* ~d~/*V* ~t~ at the bedside can be easily performed with volumetric capnography, in which both exhaled tidal volume and P~e~CO~2~ are measured. The P~e~CO~2~is compared to P~a~CO~2~ determined from the arterial blood, and the Enghoff modification of the Bohr equation is used to calculate *V* ~d~/*V* ~t~ \[[@B3]\]. *V* ~d~/*V* ~t~ has been shown to be useful in identifying cardiac surgery patients with microthrombosis of the pulmonary circulation \[[@B6]\] and ARDS patients who have an increased risk for death \[[@B7]\]. It has also been proposed to help identify patients with pulmonary embolism \[[@B8]\] and to risk-stratify intubated patients for extubation failure \[[@B9]\]. A drawback of this method is that it requires sampling of the arterial blood, which can be painful and may cause complications. Thus, a noninvasive test to estimate *V* ~d~/*V* ~t~ might be helpful.

A transcutaneous measurement of CO~2~ is based on the principle that an increase in skin capillary blood flow facilitates diffusion of CO~2~, hence allowing its detection by a sensor located at the skin surface. The sensor is also equipped with a thermostatically controlled heater unit, which allows an increase in temperature of the skin surface. The Stove-Severinghaus type CO~2~ sensor is a potentiometric sensor combining a silver/silver chloride reference electrode and a miniature glass pH electrode. P~tc~CO~2~ is determined by a change in pH of the electrolyte solution \[[@B4], [@B11]\].

P~tc~CO~2~ is a noninvasive method of estimating P~a~CO~2~ used frequently in clinical practice. Its application has been widely noted during mechanical ventilation, anesthesia, bronchoscopy, and sleep studies \[[@B4]\]. Whether substituting P~tc~CO~2~for P~a~CO~2~ yields accurate measurements of *V* ~d~/*V* ~t~ is unreported in the scientific literature. We performed a prospective pilot comparison to explore whether using P~tc~CO~2~ in place of P~a~CO~2~ in the Enghoff-Bohr calculation would yield accurate estimates of *V* ~d~/*V* ~t~. Our observations show a strong positive correlation between both methods of estimating *V* ~d~/*V* ~t~ with good agreement between the two techniques.

Our study has some limitations. First, the sample size is small. We consider our findings to be preliminary. They will require confirmation in a larger cohort of patients. Second, we conducted our study exclusively in patients who had undergone cardiac surgery, both emergent and elective. We chose this group because it is relatively homogeneous with regard to complicating respiratory and metabolic disorders, thereby minimizing residual confounders that might bias the results. Whether our findings can be extrapolated to other critically ill populations will require further investigation. For example, it is plausible that transcutaneous CO~2~measurements will be less accurate in patients with circulatory failure or shock, as peripheral blood flow may be diminished. Finally, our goal was limited. We sought to test how well *V* ~d~/*V* ~t~ calculations using P~tc~CO~2~ measurements compared to *V* ~d~/*V* ~t~ calculations using P~a~CO~2~. We did not employ a reference standard measurement of *V* ~d~/*V* ~t~ such as mixed inert gas elimination technique, as such techniques are found only in highly specialized research centers. It is possible that unmeasured confounders that affect volumetric capnography might result in random or systematic biases that make our findings unreliable. Indeed, P~tc~CO~2~ could be influenced by advanced age, hypothermia, hypercapnia, and use of vasopressor and inotropic support. A larger observational study would be essential to determine the influence of these potential confounders on *V* ~d~/*V* ~t~ measurement. Nonetheless, we believe that our methods represent a real-world approach to use bedside *V* ~d~/*V* ~t~ measurements and that P~tc~CO~2~ may be an acceptable substitute for P~a~CO~2~ to calculate *V* ~d~/*V* ~t~.

Thus, we propose that substituting P~tc~CO~2~for P~a~CO~2~ may be clinically useful and provide a noninvasive means for estimating *V* ~d~/*V* ~t~. Using a noninvasive CO~2~ measurement to calculate *V* ~d~/*V* ~t~ potentially could permit more frequent estimates of *V* ~d~/*V* ~t~ when multiple samples of arterial blood are unavailable or invasive procedures are not desired. For example, it is plausible that following the *V* ~d~/*V* ~t~ over the course of a spontaneous breathing trial could be useful at identifying patients at high risk for requiring continued mechanical ventilator support, as has been shown in pediatric patients with respiratory failure \[[@B12]\]. Future work incorporating noninvasive CO~2~ measurements into *V* ~d~/*V* ~t~ calculations should focus on whether these estimates are valid in a broader population of critically ill patients and whether *V* ~d~/*V* ~t~ measurements can be incorporated into treatment strategies to yield improved patient-centered outcomes.

5. Conclusion {#sec5}
=============

P~tc~CO~2~ may be a useful substitute for P~a~CO~2~ to calculate the dead space fraction. P~tc~CO~2~ measurements can provide a noninvasive means to measure the dead space fraction, thus allowing us to obtain important physiologic information and prognostic assessment in critically ill patients on mechanical ventilation.
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###### 

Patient demographic and clinical characteristics (*n* = 30).

  ---------------------------------------------- --------------
  Mean age (years) ± SD                          68.25 ± 6.36
  Males                                          24
  Types of cardiac surgery                        
   Valve replacement                             12
   CABG                                          12
   Valve + CABG                                  4
   Aneurysm                                      2
  Cardiopulmonary bypass status                   
   On bypass                                     26
   Off bypass                                    4
  Mean APACHE II score ± SD                      14.5 ± 3.92
  Patient comorbidities^1^                        
   Cardiovascular                                28
   Respiratory                                   6
   Endocrine                                     8
   Neurology                                     3
   Miscellaneous^*∗*^                            4
  Vasopressor or inotrope support                14
  Mean tidal volume on ventilator^2^ (mL) ± SD   660 ± 95.95
  Mean P~a~CO~2~ (mm of Hg) ± SD                 35.93 ± 5.19
  Mean P~tc~CO~2~ (mm of Hg) ± SD                39.73 ± 5.82
  Mean shunt fraction (*Q* ~s~/*Q* ~t~)^3^       0.19 ± 0.08
  ---------------------------------------------- --------------

^1^Patients may have more than one comorbidity.

^*∗*^Miscellaneous comorbidities included cirrhosis, chronic kidney disease, HIV and malignancy.

^2^All patients maintained on volume assist control mode of mechanical ventilation.

^3^Measured only in 27 patients who had a pulmonary artery catheter.

Abbreviations: CABG: coronary artery bypass graft; APACHE: acute physiology and chronic health evaluation.
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